Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

Medication Treatments

Buprenorphine: When to stop treatment
01/28/2016
Two professionals state that there is no ideal way to project the duration of buprenorphine treatment, explaining that individual patient variables should dictate whether to maintain or taper.
Two professionals state that there is no ideal way to project the duration of buprenorphine treatment, explaining that individual patient variables should dictate whether to maintain or taper.
Two professionals state that...
01/28/2016
Addiction Professional
Can addiction specialists unite on buprenorphine prescribing limits?
01/25/2016
The American Academy of Addiction Psychiatry (AAAP) would like to build consensus on buprenorphine prescribing revisions that would encourage more prescribers but also protect patient interests.
The American Academy of Addiction Psychiatry (AAAP) would like to build consensus on buprenorphine prescribing revisions that would encourage more prescribers but also protect patient interests.
The American Academy of...
01/25/2016
Addiction Professional
Blog
Vivitrol facts and free naloxone, courtesy of the police
01/22/2016
A Massachusetts town's community meeting to embrace opioid users and their families offers another example of a changing mindset in some local police agencies.
A Massachusetts town's community meeting to embrace opioid users and their families offers another example of a changing mindset in some local police agencies.
A Massachusetts town's community...
01/22/2016
Addiction Professional
A voluntary guideline on opioid prescribing for chronic pain spurs intense interest
01/18/2016
The Centers for Disease Control and Prevention (CDC) has been inundated with comments on an entirely voluntary guideline designed to minimize risk associated with prescribing of opioids for chronic pain.
The Centers for Disease Control and Prevention (CDC) has been inundated with comments on an entirely voluntary guideline designed to minimize risk associated with prescribing of opioids for chronic pain.
The Centers for Disease Control...
01/18/2016
Addiction Professional
News
Six-month buprenorphine implant gains approval of advisory panel
01/14/2016
After failing to win federal approval three years ago, developers of a subdermal implant of buprenorphine are again one step away from being able to market their formulation.
After failing to win federal approval three years ago, developers of a subdermal implant of buprenorphine are again one step away from being able to market their formulation.
After failing to win federal...
01/14/2016
Addiction Professional
Addiction specialists report growing struggle to meet demand for medication treatment
01/07/2016
With possible revisions to buprenorphine prescribing limits looming, respondents to an American Society of Addiction Medicine (ASAM) survey report increasing difficulty in meeting demand for the opioid addiction treatment.
With possible revisions to buprenorphine prescribing limits looming, respondents to an American Society of Addiction Medicine (ASAM) survey report increasing difficulty in meeting demand for the opioid addiction treatment.
With possible revisions to...
01/07/2016
Addiction Professional
Older patients can benefit from MI to prevent opioid misuse
12/19/2015
New research suggests that the strengths-based approach inherent in Motivational Interviewing (MI) can help older-adult pain patients at risk of opioid misuse or abuse.
New research suggests that the strengths-based approach inherent in Motivational Interviewing (MI) can help older-adult pain patients at risk of opioid misuse or abuse.
New research suggests that the...
12/19/2015
Addiction Professional
Blog
Methadone providers assert their role
12/09/2015
Amid progress in initiatives to combat opioid addiction, the association representing methadone-focused treatment programs remains committed to ensuring that methadone treatment isn't left behind.
Amid progress in initiatives to combat opioid addiction, the association representing methadone-focused treatment programs remains committed to ensuring that methadone treatment isn't left behind.
Amid progress in initiatives to...
12/09/2015
Addiction Professional
News
Nasal-spray version of overdose reversal drug wins FDA approval
11/19/2015
A nasal-spray formulation of the opioid overdose reversal drug naloxone should now be available to first responders and the public by early 2016.
A nasal-spray formulation of the opioid overdose reversal drug naloxone should now be available to first responders and the public by early 2016.
A nasal-spray formulation of the...
11/19/2015
Addiction Professional
News
AMA addresses naloxone, drug ads in policy statements
11/17/2015
The American Medical Association's House of Delegates this week has adopted several new policies, including one to encourage the development of over-the-counter formulations of naloxone.
The American Medical Association's House of Delegates this week has adopted several new policies, including one to encourage the development of over-the-counter formulations of naloxone.
The American Medical...
11/17/2015
Addiction Professional

Advertisement

Advertisement

Browse Our Other Brands

Psych NP Institute

 

Psych Congress Network

 

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use

Advertisement